| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |